MedTrace Logo

Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland

NCT03516747 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-04-11

No results posted yet for this study

Summary

Identification and localization of pathological parathyroid gland before parathyroidectomy is traditionally done by a combination of two methods: ultrasound and sestamibi scan. The investigators would like to show that one exam that includes ultrasound and fine needle aspiration of the parathyroid gland for parathyroid hormone level is as accurate as the traditional method.

Conditions

  • Parathyroid Adenoma
  • Hypercalcemia

Interventions

DIAGNOSTIC_TEST

pre operative parathyroid hormone level measurement

At the clinic, the participants will undergo ultrasound examination with fine needle aspiration. The aspirated material will be sent for parathyroid hormone level measurement.

DIAGNOSTIC_TEST

pre operative parathyroid cytology

At the clinic, the participants will undergo neck ultrasound examination with fine needle aspiration. The aspirated material will be sent for cytology examination.

DIAGNOSTIC_TEST

parathyroid hormone level measurement

At surgery, after the pathologic gland is excised , the gland will be aspirated. The material will be sent for parathyroid hormone level measurement.

DIAGNOSTIC_TEST

parathyroid cytology

At surgery, after the pathologic gland is excised , it will be aspirated again for cytologic examination.

Sponsors & Collaborators

  • HaEmek Medical Center, Israel

    lead OTHER

Principal Investigators

  • Dror Ashkenazi, M.D · haemek medical center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-09
Primary Completion
2020-04-09
Completion
2020-08-09

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03516747 on ClinicalTrials.gov